Potassium-sparing Diuretic [EPC]

Potassium-sparing Diuretic [EPC] was reported 13395 times

Drugs of the Potassium-sparing Diuretic [EPC] class are most commonly taken among patients reporting these side effects:

# Drug class Count Frequency
0 CRYSTAL NEPHROPATHY 12 0.0203
1 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 21 0.0198
2 REBOUND ACID HYPERSECRETION 56 0.0185
3 NEPHROGENIC ANAEMIA 67 0.0144
4 ANAEMIA OF CHRONIC DISEASE 12 0.0133
5 HYPERPARATHYROIDISM SECONDARY 33 0.0132
6 VERTEBRAL FORAMINAL STENOSIS 10 0.0121
7 LEFT ATRIAL DILATATION 13 0.0102
8 PATHOLOGICAL GAMBLING 16 0.0096
9 DIABETIC NEUROPATHY 44 0.0089
10 HYPERTENSIVE HEART DISEASE 15 0.0080
11 HAIR DISORDER 64 0.0078
12 HYPOCHLORAEMIA 9 0.0077
13 FOCAL SEGMENTAL GLOMERULOSCLEROSIS 12 0.0075
14 CHRONIC KIDNEY DISEASE 561 0.0074
15 CARDIOACTIVE DRUG LEVEL INCREASED 9 0.0068
16 PSYCHOLOGICAL TRAUMA 58 0.0067
17 ESSENTIAL HYPERTENSION 12 0.0066
18 MENISCUS LESION 9 0.0065
19 KYPHOSIS 11 0.0062
20 HAIR TEXTURE ABNORMAL 83 0.0062
21 HAIR COLOUR CHANGES 76 0.0061
22 COLONIC POLYP 10 0.0060
23 HEART INJURY 15 0.0060
24 VENTRICULAR HYPERTROPHY 15 0.0060
25 SPINAL COLUMN STENOSIS 28 0.0059
26 END STAGE RENAL DISEASE 108 0.0059
27 THERAPEUTIC AGENT TOXICITY 18 0.0054
28 BILIARY DYSKINESIA 9 0.0053
29 MADAROSIS 59 0.0051
30 SPINAL OSTEOARTHRITIS 44 0.0050
31 ELECTRIC SHOCK SENSATION 14 0.0050
32 BUNDLE BRANCH BLOCK LEFT 21 0.0049
33 BLOOD CHLORIDE DECREASED 12 0.0046
34 ELECTROCARDIOGRAM ST SEGMENT DEPRESSION 10 0.0045
35 TUBULOINTERSTITIAL NEPHRITIS 83 0.0044
36 BLOOD POTASSIUM DECREASED 127 0.0042
37 LEFT VENTRICULAR HYPERTROPHY 18 0.0042
38 RADICULOPATHY 11 0.0042
39 NERVE COMPRESSION 38 0.0041
40 HYPERPHAGIA 16 0.0040
41 CANDIDIASIS 16 0.0040
42 THROMBOPHLEBITIS SUPERFICIAL 12 0.0040
43 HAEMORRHAGIC DIATHESIS 14 0.0039
44 AORTIC ARTERIOSCLEROSIS 10 0.0039
45 HYPERLIPIDAEMIA 46 0.0038
46 HEPATIC CYST 13 0.0038
47 PHARYNGEAL DISORDER 11 0.0038
48 HYPERKERATOSIS 21 0.0038
49 INTERVERTEBRAL DISC DEGENERATION 35 0.0038
50 LUMBAR SPINAL STENOSIS 11 0.0038
51 ORAL INTAKE REDUCED 9 0.0037
52 PRE-EXISTING CONDITION IMPROVED 23 0.0037
53 INFLAMMATORY MARKER INCREASED 18 0.0036
54 THYROID FUNCTION TEST ABNORMAL 15 0.0036
55 HYPOVOLAEMIA 21 0.0036
56 PLANTAR FASCIITIS 12 0.0036
57 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 18 0.0036
58 SCOLIOSIS 22 0.0035
59 MITRAL VALVE INCOMPETENCE 40 0.0035
60 TRICUSPID VALVE INCOMPETENCE 28 0.0035
61 LUNG NEOPLASM 15 0.0035
62 MULTIPLE INJURIES 22 0.0035
63 ATRIOVENTRICULAR BLOCK FIRST DEGREE 15 0.0035
64 ECONOMIC PROBLEM 52 0.0034
65 RENAL INJURY 101 0.0034
66 HIATUS HERNIA 44 0.0034
67 RENAL FAILURE CHRONIC 26 0.0034
68 BODY HEIGHT DECREASED 36 0.0034
69 ILEUS PARALYTIC 15 0.0034
70 OSTEOARTHRITIS 140 0.0033
71 RENAL CYST 26 0.0033
72 ROTATOR CUFF SYNDROME 42 0.0033
73 POLYARTHRITIS 17 0.0032
74 RENAL FAILURE 425 0.0032
75 HAEMORRHAGIC ANAEMIA 14 0.0032
76 BLOOD SODIUM DECREASED 60 0.0032
77 GASTROOESOPHAGEAL REFLUX DISEASE 255 0.0032
78 AORTIC STENOSIS 11 0.0032
79 PARANASAL SINUS HYPERSECRETION 12 0.0031
80 HYPERTONIC BLADDER 9 0.0031
81 ATELECTASIS 30 0.0031
82 MENISCUS INJURY 19 0.0031
83 RENAL TUBULAR NECROSIS 30 0.0031
84 BURSITIS 37 0.0030
85 SLEEP APNOEA SYNDROME 58 0.0030
86 CEREBROVASCULAR DISORDER 9 0.0030
87 TONGUE ULCERATION 10 0.0030
88 DIVERTICULUM 21 0.0030
89 DIASTOLIC DYSFUNCTION 9 0.0029
90 JOINT EFFUSION 20 0.0029
91 ARTERIOSCLEROSIS CORONARY ARTERY 19 0.0029
92 ABDOMINAL ADHESIONS 9 0.0028
93 EXOSTOSIS 26 0.0028
94 NON-CARDIAC CHEST PAIN 9 0.0028
95 ULCER HAEMORRHAGE 19 0.0028
96 FACIAL BONES FRACTURE 10 0.0028
97 STRESS CARDIOMYOPATHY 16 0.0027
98 TONGUE DISCOLOURATION 12 0.0027
99 UTERINE LEIOMYOMA 20 0.0027
100 BLOOD PHOSPHORUS DECREASED 10 0.0027
101 PNEUMONIA ASPIRATION 68 0.0027
102 BLOOD PRESSURE DIASTOLIC DECREASED 20 0.0027
103 CORONARY ARTERY OCCLUSION 37 0.0027
104 RENAL FAILURE ACUTE 114 0.0027
105 GOUT 48 0.0027
106 CARPAL TUNNEL SYNDROME 37 0.0026
107 CORONARY ARTERY DISEASE 80 0.0026
108 OSTEOPENIA 40 0.0026
109 COMPRESSION FRACTURE 14 0.0026
110 AORTIC VALVE INCOMPETENCE 11 0.0026
111 CAROTID ARTERY STENOSIS 9 0.0026
112 IMPAIRED QUALITY OF LIFE 37 0.0026
113 LOWER GASTROINTESTINAL HAEMORRHAGE 19 0.0026
114 MULTIPLE ALLERGIES 20 0.0025
115 CHOLECYSTITIS CHRONIC 17 0.0025
116 JOINT RANGE OF MOTION DECREASED 34 0.0025
117 PERIPHERAL VASCULAR DISORDER 13 0.0025
118 GLOMERULAR FILTRATION RATE DECREASED 31 0.0025
119 CARDIOMEGALY 31 0.0025
120 STOMACH DISCOMFORT 13 0.0025
121 FRUSTRATION 9 0.0025
122 AZOTAEMIA 10 0.0025
123 FAECAL INCONTINENCE 12 0.0025
124 ACUTE KIDNEY INJURY 381 0.0025
125 ANOREXIA 32 0.0025
126 INTERNATIONAL NORMALISED RATIO DECREASED 10 0.0025
127 CAROTID ARTERY OCCLUSION 9 0.0025
128 HAEMORRHOIDAL HAEMORRHAGE 12 0.0025
129 BLOOD UREA INCREASED 41 0.0024
130 ARTERIOSCLEROSIS 23 0.0024
131 BLINDNESS TRANSIENT 18 0.0024
132 OEDEMA PERIPHERAL 297 0.0024
133 HEART RATE IRREGULAR 55 0.0024
134 BLOOD MAGNESIUM DECREASED 21 0.0024
135 ELECTROCARDIOGRAM ABNORMAL 19 0.0024
136 APPETITE DISORDER 16 0.0024
137 STRESS FRACTURE 13 0.0024
138 CORONARY ARTERY STENOSIS 12 0.0024
139 SYNOVIAL CYST 11 0.0024
140 SINUS HEADACHE 14 0.0024
141 FOOT DEFORMITY 26 0.0023
142 HYPOKALAEMIA 108 0.0023
143 SKIN TIGHTNESS 11 0.0023
144 BLOOD PRESSURE INADEQUATELY CONTROLLED 14 0.0023
145 HYPONATRAEMIA 131 0.0023
146 ACTIVITIES OF DAILY LIVING IMPAIRED 46 0.0023
147 CARDIAC FLUTTER 15 0.0023
148 ANGINA UNSTABLE 15 0.0023
149 MYOCARDIAL ISCHAEMIA 26 0.0023
150 FOOT FRACTURE 43 0.0023
151 CEREBRAL ATROPHY 9 0.0023
152 PHARYNGOLARYNGEAL PAIN 12 0.0023
153 NEPHROPATHY 21 0.0022
154 GALLBLADDER DISORDER 40 0.0022
155 VENTRICULAR TACHYCARDIA 37 0.0022
156 MUSCULOSKELETAL DISCOMFORT 38 0.0022
157 PERIPHERAL ARTERIAL OCCLUSIVE DISEASE 9 0.0022
158 CARDIAC MURMUR 19 0.0022
159 JOINT DISLOCATION 23 0.0022
160 EYE OPERATION 10 0.0022
161 ANHEDONIA 57 0.0022
162 PATHOLOGICAL FRACTURE 11 0.0022
163 BLOOD CHOLESTEROL ABNORMAL 10 0.0022
164 TYPE 1 DIABETES MELLITUS 13 0.0022
165 VITAMIN D DEFICIENCY 21 0.0022
166 INTERVERTEBRAL DISC PROTRUSION 47 0.0021
167 ELECTROCARDIOGRAM QRS COMPLEX PROLONGED 11 0.0021
168 TIBIA FRACTURE 10 0.0021
169 BENIGN PROSTATIC HYPERPLASIA 11 0.0021
170 TYPE 2 DIABETES MELLITUS 71 0.0021
171 INTERVERTEBRAL DISC DISORDER 9 0.0021
172 DYSPHONIA 123 0.0021
173 AORTIC ANEURYSM 16 0.0021
174 HAEMORRHOIDS 41 0.0021
175 MICTURITION URGENCY 24 0.0021
176 HEPATIC LESION 9 0.0021
177 VISUAL FIELD DEFECT 15 0.0021
178 LOW DENSITY LIPOPROTEIN INCREASED 16 0.0021
179 SKIN WARM 12 0.0021
180 FIBROMYALGIA 50 0.0021
181 SPINAL COMPRESSION FRACTURE 17 0.0021
182 LYMPHOPENIA 29 0.0020
183 ECCHYMOSIS 14 0.0020
184 ARTERIAL OCCLUSIVE DISEASE 16 0.0020
185 DRY MOUTH 165 0.0020
186 CHEILITIS 11 0.0020
187 BONE DISORDER 37 0.0020
188 GLUCOSE TOLERANCE IMPAIRED 12 0.0020
189 FLANK PAIN 19 0.0020
190 CATARACT OPERATION 12 0.0020
191 RHINITIS ALLERGIC 9 0.0020
192 LARGE INTESTINE POLYP 14 0.0020
193 EXPIRED DRUG ADMINISTERED 10 0.0020
194 LACERATION 19 0.0020
195 CARDIAC PACEMAKER INSERTION 12 0.0020
196 ATRIAL FLUTTER 16 0.0020
197 MUSCULOSKELETAL PAIN 105 0.0020
198 LIMB DISCOMFORT 62 0.0020
199 VEIN DISORDER 10 0.0020
200 OBSESSIVE-COMPULSIVE DISORDER 16 0.0020
201 VITAMIN D DECREASED 17 0.0020
202 HYPERSOMNIA 57 0.0020
203 TRANSIENT ISCHAEMIC ATTACK 67 0.0020
204 SEASONAL ALLERGY 28 0.0020
205 MUSCLE DISORDER 16 0.0020
206 DYSGRAPHIA 13 0.0020
207 WALKING AID USER 13 0.0020
208 HYPERCHOLESTEROLAEMIA 19 0.0020
209 DRY THROAT 20 0.0020
210 MUSCLE STRAIN 17 0.0020
211 PHARMACEUTICAL PRODUCT COMPLAINT 51 0.0020
212 POLYURIA 16 0.0020
213 CONTUSION 188 0.0020
214 LEFT VENTRICULAR DYSFUNCTION 13 0.0019
215 BLOOD CALCIUM INCREASED 17 0.0019
216 PHOTOSENSITIVITY REACTION 32 0.0019
217 BASAL CELL CARCINOMA 30 0.0019
218 LIGAMENT SPRAIN 19 0.0019
219 GLAUCOMA 37 0.0019
220 JOINT INJURY 41 0.0019
221 KNEE ARTHROPLASTY 40 0.0019
222 TOOTH INFECTION 25 0.0019
223 FEAR 51 0.0019
224 NOCTURIA 23 0.0019
225 BLOOD ALBUMIN DECREASED 15 0.0019
226 POLLAKIURIA 78 0.0019
227 RESTLESS LEGS SYNDROME 34 0.0019
228 BLOOD TRIGLYCERIDES INCREASED 33 0.0019
229 HAEMATOCRIT DECREASED 37 0.0019
230 ENERGY INCREASED 11 0.0019
231 OVERWEIGHT 10 0.0019
232 BLOOD IRON DECREASED 22 0.0019
233 BALANCE DISORDER 160 0.0018
234 INCREASED TENDENCY TO BRUISE 17 0.0018
235 UPPER GASTROINTESTINAL HAEMORRHAGE 31 0.0018
236 DECUBITUS ULCER 15 0.0018
237 PAIN IN JAW 52 0.0018
238 VITREOUS FLOATERS 18 0.0018
239 BRONCHITIS 135 0.0018
240 SQUAMOUS CELL CARCINOMA OF SKIN 11 0.0018
241 MIDDLE INSOMNIA 34 0.0018
242 UPPER-AIRWAY COUGH SYNDROME 15 0.0018
243 PERIPHERAL COLDNESS 25 0.0018
244 SCIATICA 29 0.0018
245 FOOT OPERATION 9 0.0018
246 LUNG INFILTRATION 16 0.0018
247 ERUCTATION 35 0.0018
248 ANKLE FRACTURE 28 0.0018
249 CONCUSSION 14 0.0018
250 ANEURYSM 9 0.0018
251 NERVE INJURY 20 0.0018
252 NECK PAIN 100 0.0018
253 ORAL PAIN 40 0.0018
254 ANGIOPATHY 10 0.0018
255 BACK DISORDER 29 0.0018
256 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 93 0.0018
257 TENDON RUPTURE 22 0.0018
258 FLUSHING 181 0.0018
259 DYSPEPSIA 175 0.0018
260 POSTOPERATIVE WOUND INFECTION 12 0.0018
261 ABNORMAL DREAMS 49 0.0018
262 NASAL DISCOMFORT 14 0.0018
263 INJURY 124 0.0018
264 IMPAIRED DRIVING ABILITY 20 0.0018
265 SINUS BRADYCARDIA 17 0.0018
266 OBESITY 28 0.0018
267 CARDIAC FAILURE CONGESTIVE 141 0.0018
268 ARTHRITIS 138 0.0018
269 CHOLECYSTECTOMY 20 0.0017
270 EAR PAIN 34 0.0017
271 DIABETES MELLITUS 133 0.0017
272 MUSCLE SPASMS 320 0.0017
273 LYMPHOEDEMA 12 0.0017
274 ALOPECIA 340 0.0017
275 OSTEOPOROSIS 71 0.0017
276 HAND FRACTURE 12 0.0017
277 DEEP VEIN THROMBOSIS 110 0.0017
278 PHARYNGEAL OEDEMA 26 0.0017
279 IRRITABLE BOWEL SYNDROME 36 0.0017
280 BLOOD CHOLESTEROL INCREASED 78 0.0017
281 PROTHROMBIN TIME PROLONGED 10 0.0017
282 BRUXISM 9 0.0017
283 GINGIVITIS 9 0.0017
284 MENTAL STATUS CHANGES 46 0.0017
285 BACK INJURY 18 0.0017
286 ATRIAL FIBRILLATION 161 0.0017
287 GLOSSODYNIA 37 0.0017
288 FLUID OVERLOAD 24 0.0016
289 BLOOD COUNT ABNORMAL 25 0.0016
290 APHONIA 23 0.0016
291 IMPAIRED HEALING 54 0.0016
292 INGUINAL HERNIA 10 0.0016
293 RETCHING 35 0.0016
294 FURUNCLE 13 0.0016
295 TOOTH FRACTURE 18 0.0016
296 CHOKING SENSATION 9 0.0016
297 BLOOD PRESSURE INCREASED 249 0.0016
298 DENTAL CARIES 18 0.0016
299 GRAND MAL CONVULSION 15 0.0016
300 BLOOD CREATININE INCREASED 106 0.0016
301 OEDEMA 88 0.0016
302 MOVEMENT DISORDER 52 0.0016
303 PIGMENTATION DISORDER 10 0.0016
304 ARTHROPOD BITE 12 0.0016
305 CHOLELITHIASIS 53 0.0016
306 SINUS DISORDER 32 0.0016
307 FEELING DRUNK 12 0.0016
308 HEART RATE ABNORMAL 9 0.0016
309 FLATULENCE 91 0.0016
310 AGEUSIA 40 0.0016
311 NASAL DRYNESS 10 0.0016
312 PAROSMIA 12 0.0016
313 INFUSION SITE SWELLING 10 0.0016
314 CHOLECYSTITIS ACUTE 9 0.0016
315 GENERALISED ERYTHEMA 9 0.0016
316 TOOTH ABSCESS 16 0.0016
317 FOREIGN BODY SENSATION IN EYES 10 0.0016
318 SLUGGISHNESS 16 0.0016
319 TINNITUS 72 0.0016
320 BOWEL MOVEMENT IRREGULARITY 12 0.0016
321 GASTRITIS 41 0.0016
322 JOINT SWELLING 188 0.0016
323 RALES 9 0.0015
324 LOCAL SWELLING 27 0.0015
325 STAPHYLOCOCCAL INFECTION 51 0.0015
326 MUSCLE TIGHTNESS 25 0.0015
327 HYPERTRIGLYCERIDAEMIA 9 0.0015
328 DEHYDRATION 205 0.0015
329 PULMONARY EMBOLISM 146 0.0015
330 FLUID RETENTION 78 0.0015
331 REFUSAL OF TREATMENT BY PATIENT 10 0.0015
332 FUNGAL INFECTION 51 0.0015
333 DECREASED INTEREST 9 0.0015
334 GASTRIC ULCER 29 0.0015
335 PARAESTHESIA ORAL 22 0.0015
336 SOMNAMBULISM 10 0.0015
337 SINUSITIS 156 0.0015
338 PRESYNCOPE 37 0.0015
339 NIGHT SWEATS 49 0.0015
340 SCAR 26 0.0015
341 INJECTION SITE HAEMATOMA 22 0.0015
342 THERAPEUTIC RESPONSE UNEXPECTED 68 0.0015
343 BACK PAIN 352 0.0015
344 INCONTINENCE 16 0.0015
345 HYPERKALAEMIA 53 0.0015
346 PAIN IN EXTREMITY 445 0.0015
347 BLOOD PRESSURE ABNORMAL 30 0.0015
348 HYSTERECTOMY 13 0.0015
349 ORAL DISORDER 11 0.0015
350 ACUTE MYOCARDIAL INFARCTION 44 0.0015
351 THYROID DISORDER 23 0.0015
352 TOOTHACHE 27 0.0015
353 URINE OUTPUT DECREASED 13 0.0015
354 PERIPHERAL SWELLING 229 0.0015
355 PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 9 0.0015
356 GAIT DISTURBANCE 283 0.0015
357 MUSCULAR WEAKNESS 168 0.0015
358 FAECES DISCOLOURED 32 0.0015
359 SWOLLEN TONGUE 46 0.0015
360 UPPER RESPIRATORY TRACT INFECTION 68 0.0015
361 RIB FRACTURE 30 0.0015
362 FACIAL PAIN 13 0.0015
363 HYPERTENSION 308 0.0015
364 DEAFNESS 38 0.0015
365 URINARY INCONTINENCE 43 0.0014
366 DEPRESSION 330 0.0014
367 COMA 69 0.0014
368 VENTRICULAR EXTRASYSTOLES 15 0.0014
369 CONSTIPATION 315 0.0014
370 DYSURIA 53 0.0014
371 HYPOAESTHESIA 215 0.0014
372 COORDINATION ABNORMAL 20 0.0014
373 PRURITUS GENERALISED 31 0.0014
374 MACULAR DEGENERATION 17 0.0014
375 INFUSION SITE ERYTHEMA 12 0.0014
376 HEAD INJURY 45 0.0014
377 TENDONITIS 22 0.0014
378 EYE INFECTION 16 0.0014
379 RENAL PAIN 15 0.0014
380 INSOMNIA 376 0.0014
381 BLADDER DISORDER 14 0.0014
382 THERMAL BURN 10 0.0014
383 HAEMORRHAGIC STROKE 11 0.0014
384 WRONG TECHNIQUE IN DRUG USAGE PROCESS 51 0.0014
385 FEELING COLD 39 0.0014
386 AFFECTIVE DISORDER 11 0.0014
387 TOOTH DISORDER 31 0.0014
388 INCOHERENT 9 0.0014
389 EPISTAXIS 104 0.0014
390 FEELING ABNORMAL 332 0.0014
391 PANIC REACTION 10 0.0014
392 TONGUE DISORDER 10 0.0014
393 LIP SWELLING 46 0.0014
394 DYSPNOEA EXERTIONAL 52 0.0014
395 NODULE 18 0.0014
396 FALL 458 0.0014
397 POLYP 9 0.0014
398 BLOOD DISORDER 11 0.0014
399 WEIGHT DECREASED 383 0.0014
400 BLOOD URINE PRESENT 26 0.0014
401 ORAL DISCOMFORT 19 0.0014
402 INITIAL INSOMNIA 14 0.0014
403 RED BLOOD CELL COUNT DECREASED 39 0.0014
404 LIMB INJURY 37 0.0014
405 DYSGEUSIA 101 0.0014
406 NERVOUSNESS 71 0.0014
407 HEMIPARESIS 23 0.0014
408 MUSCULOSKELETAL CHEST PAIN 21 0.0014
409 SKIN ULCER 35 0.0014
410 ASTHENIA 509 0.0014
411 HEART RATE INCREASED 134 0.0014
412 BONE PAIN 79 0.0013
413 HERNIA 26 0.0013
414 FULL BLOOD COUNT DECREASED 27 0.0013
415 SKIN INFECTION 15 0.0013
416 DYSSTASIA 39 0.0013
417 ABASIA 33 0.0013
418 WRIST FRACTURE 16 0.0013
419 BLOOD CALCIUM DECREASED 15 0.0013
420 BLOOD PRESSURE SYSTOLIC INCREASED 26 0.0013
421 INTERNATIONAL NORMALISED RATIO INCREASED 38 0.0013
422 CHOKING 26 0.0013
423 ACUTE CORONARY SYNDROME 11 0.0013
424 HYPOAESTHESIA ORAL 20 0.0013
425 ANGINA PECTORIS 38 0.0013
426 SOMNOLENCE 267 0.0013
427 DIZZINESS 659 0.0013
428 ABNORMAL LOSS OF WEIGHT 9 0.0013
429 VISION BLURRED 181 0.0013
430 INCORRECT DRUG ADMINISTRATION DURATION 37 0.0013
431 ROAD TRAFFIC ACCIDENT 55 0.0013
432 TROPONIN INCREASED 10 0.0013
433 ANXIETY 374 0.0013
434 MYALGIA 223 0.0013
435 CELLULITIS 66 0.0013
436 UNEVALUABLE EVENT 99 0.0013
437 WEIGHT INCREASED 293 0.0013
438 ABDOMINAL PAIN UPPER 269 0.0013
439 LIPASE INCREASED 10 0.0013
440 FEELING HOT 80 0.0013
441 OVARIAN CYST 13 0.0013
442 SKIN CANCER 28 0.0013
443 HAIR GROWTH ABNORMAL 9 0.0013
444 IRON DEFICIENCY ANAEMIA 12 0.0013
445 RHINORRHOEA 84 0.0013
446 DIABETES MELLITUS INADEQUATE CONTROL 23 0.0013
447 BURNING SENSATION 91 0.0013
448 VERTIGO 79 0.0013
449 THROAT IRRITATION 58 0.0013
450 RASH PRURITIC 70 0.0013
451 EMPHYSEMA 13 0.0013
452 UNDERDOSE 94 0.0013
453 EJECTION FRACTION DECREASED 20 0.0013
454 CARDIOMYOPATHY 19 0.0013
455 SKIN DISCOLOURATION 59 0.0013
456 DIARRHOEA HAEMORRHAGIC 12 0.0013
457 NEUROPATHY PERIPHERAL 122 0.0013
458 TASTE DISORDER 26 0.0013
459 OESOPHAGITIS 14 0.0013
460 BLOOD TEST ABNORMAL 18 0.0013
461 PSORIATIC ARTHROPATHY 52 0.0013
462 DRUG EFFECT DECREASED 69 0.0013
463 GASTROINTESTINAL HAEMORRHAGE 107 0.0013
464 CATARACT 76 0.0013
465 SQUAMOUS CELL CARCINOMA 12 0.0013
466 INJECTION SITE NODULE 14 0.0013
467 COUGH 355 0.0013
468 PALPITATIONS 148 0.0013
469 DIVERTICULITIS 35 0.0013
470 MUSCLE ATROPHY 16 0.0013
471 TEMPERATURE INTOLERANCE 13 0.0013
472 ARTHROPATHY 70 0.0013
473 FEELING JITTERY 24 0.0013
474 SYNCOPE 126 0.0013
475 CYSTITIS 40 0.0013
476 LABORATORY TEST ABNORMAL 37 0.0013
477 SNEEZING 28 0.0012
478 PULMONARY HYPERTENSION 26 0.0012
479 EMOTIONAL DISTRESS 151 0.0012
480 HOT FLUSH 94 0.0012
481 OCULAR DISCOMFORT 14 0.0012
482 EYE PAIN 70 0.0012
483 HIP ARTHROPLASTY 19 0.0012
484 RHINITIS 10 0.0012
485 MYASTHENIA GRAVIS 10 0.0012
486 HEPATIC STEATOSIS 23 0.0012
487 PAIN 758 0.0012
488 ARTHRALGIA 513 0.0012
489 MOUTH HAEMORRHAGE 9 0.0012
490 LACRIMATION INCREASED 37 0.0012
491 CHEST DISCOMFORT 125 0.0012
492 LETHARGY 70 0.0012
493 HYPERCALCAEMIA 15 0.0012
494 MULTI-ORGAN FAILURE 21 0.0012
495 SKIN HAEMORRHAGE 18 0.0012
496 RENAL IMPAIRMENT 102 0.0012
497 URINARY TRACT INFECTION 207 0.0012
498 RECTAL HAEMORRHAGE 52 0.0012
499 MUSCULOSKELETAL STIFFNESS 106 0.0012
500 PULMONARY MASS 18 0.0012
501 PARAESTHESIA 190 0.0012
502 DECREASED ACTIVITY 13 0.0012
503 STOMATITIS 73 0.0012
504 RENAL DISORDER 56 0.0012
505 COAGULOPATHY 20 0.0012
506 SKIN DISORDER 40 0.0012
507 LOCALISED INFECTION 29 0.0012
508 SPINAL FRACTURE 24 0.0012
509 ABDOMINAL DISTENSION 125 0.0012
510 RESPIRATORY TRACT CONGESTION 19 0.0012
511 ACUTE RESPIRATORY FAILURE 23 0.0012
512 BLOOD THYROID STIMULATING HORMONE INCREASED 11 0.0012
513 METASTASES TO LIVER 21 0.0012
514 FEMUR FRACTURE 37 0.0012
515 ULCER 19 0.0012
516 SINUS CONGESTION 16 0.0012
517 CRYING 43 0.0012
518 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 84 0.0012
519 THINKING ABNORMAL 22 0.0012
520 BLISTER 66 0.0012
521 MYOCLONUS 14 0.0012
522 INTRAOCULAR PRESSURE INCREASED 15 0.0012
523 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 20 0.0012
524 CHEST PAIN 216 0.0012
525 CEREBROVASCULAR ACCIDENT 197 0.0012
526 HYPOCALCAEMIA 22 0.0012
527 PROSTATIC SPECIFIC ANTIGEN INCREASED 16 0.0012
528 POOR QUALITY SLEEP 25 0.0012
529 BREAST CANCER FEMALE 31 0.0012
530 OSTEOMYELITIS 21 0.0012
531 APHASIA 35 0.0012
532 DRUG EFFECT INCOMPLETE 42 0.0012
533 DECREASED APPETITE 268 0.0012
534 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 11 0.0012
535 HYPERHIDROSIS 148 0.0011
536 ORTHOSTATIC HYPOTENSION 20 0.0011
537 PSORIASIS 150 0.0011
538 WHITE BLOOD CELL COUNT INCREASED 44 0.0011
539 OROPHARYNGEAL PAIN 106 0.0011
540 CYANOSIS 18 0.0011
541 VISUAL ACUITY REDUCED 38 0.0011
542 THROMBOSIS 92 0.0011
543 DERMATITIS CONTACT 13 0.0011
544 HAEMOGLOBIN DECREASED 117 0.0011
545 DYSPHAGIA 108 0.0011
546 INTERNAL HAEMORRHAGE 13 0.0011
547 PRURITUS 437 0.0011
548 PNEUMOTHORAX 18 0.0011
549 HYPOPHAGIA 29 0.0011
550 DIZZINESS POSTURAL 11 0.0011
551 SUDDEN DEATH 12 0.0011
552 SWELLING 106 0.0011
553 GENERALISED OEDEMA 14 0.0011
554 LYMPHADENOPATHY 40 0.0011
555 GASTRIC HAEMORRHAGE 13 0.0011
556 ANAEMIA 215 0.0011
557 SINUS TACHYCARDIA 16 0.0011
558 ABDOMINAL DISCOMFORT 189 0.0011
559 BREAST PAIN 12 0.0011
560 HYPERGLYCAEMIA 41 0.0011
561 PHARYNGEAL SWELLING 11 0.0011
562 AMNESIA 73 0.0011
563 ELECTROLYTE IMBALANCE 13 0.0011
564 DYSPNOEA 633 0.0011
565 SECRETION DISCHARGE 14 0.0011
566 FATIGUE 870 0.0011
567 COMPLETED SUICIDE 93 0.0011
568 BLOOD PRESSURE DECREASED 74 0.0011
569 MYOCARDIAL INFARCTION 194 0.0011
570 DYSKINESIA 45 0.0011
571 JOINT STIFFNESS 29 0.0011
572 EYE SWELLING 41 0.0011
573 DIARRHOEA 711 0.0011
574 SALIVARY HYPERSECRETION 11 0.0011
575 TARDIVE DYSKINESIA 31 0.0011
576 GINGIVAL BLEEDING 15 0.0011
577 WHEEZING 65 0.0011
578 PULMONARY OEDEMA 49 0.0011
579 MOUTH ULCERATION 23 0.0011
580 NASAL CONGESTION 64 0.0011
581 UNRESPONSIVE TO STIMULI 28 0.0011
582 RED BLOOD CELL SEDIMENTATION RATE INCREASED 12 0.0011
583 EMBOLISM 9 0.0011
584 HERPES ZOSTER 62 0.0011
585 TREMOR 179 0.0011
586 BODY TEMPERATURE INCREASED 22 0.0011
587 HYPOMAGNESAEMIA 15 0.0011
588 MEMORY IMPAIRMENT 148 0.0011
589 ARRHYTHMIA 51 0.0011
590 PRODUCT SUBSTITUTION ISSUE 62 0.0011
591 HAEMOPTYSIS 30 0.0011
592 BRADYCARDIA 57 0.0011
593 HEAD DISCOMFORT 19 0.0011
594 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 11 0.0011
595 NEPHROPATHY TOXIC 12 0.0011
596 SPEECH DISORDER 56 0.0011
597 HYPOTHYROIDISM 34 0.0011
598 DRY EYE 53 0.0011
599 EYE DISCHARGE 11 0.0011
600 RASH MACULAR 37 0.0011
601 UPPER LIMB FRACTURE 21 0.0011
602 GASTROENTERITIS VIRAL 19 0.0011
603 SCAB 12 0.0011
604 WEIGHT FLUCTUATION 11 0.0011
605 MUSCULOSKELETAL DISORDER 20 0.0010
606 PRODUCT ODOUR ABNORMAL 11 0.0010
607 LEUKOCYTOSIS 19 0.0010
608 PSEUDOMONAS INFECTION 9 0.0010
609 EYE HAEMORRHAGE 14 0.0010
610 PHARYNGITIS 13 0.0010
611 MALIGNANT MELANOMA 14 0.0010
612 TOOTH EXTRACTION 13 0.0010
613 RASH GENERALISED 27 0.0010
614 LOWER LIMB FRACTURE 20 0.0010
615 NAUSEA 823 0.0010
616 MULTIPLE FRACTURES 17 0.0010
617 EATING DISORDER 22 0.0010
618 LIVER FUNCTION TEST ABNORMAL 30 0.0010
619 NEURALGIA 25 0.0010
620 HIP FRACTURE 33 0.0010
621 EYE IRRITATION 59 0.0010
622 ORAL HERPES 20 0.0010
623 SPLENOMEGALY 12 0.0010
624 EXPIRED PRODUCT ADMINISTERED 34 0.0010
625 COLD SWEAT 18 0.0010
626 SKIN LESION 28 0.0010
627 NASOPHARYNGITIS 188 0.0010
628 APPLICATION SITE RASH 14 0.0010
629 ERECTILE DYSFUNCTION 26 0.0010
630 SKIN LACERATION 11 0.0010
631 PULMONARY THROMBOSIS 11 0.0010
632 INFUSION SITE PAIN 13 0.0010
633 CHOLECYSTITIS 12 0.0010
634 INABILITY TO AFFORD MEDICATION 10 0.0010
635 LOSS OF CONSCIOUSNESS 129 0.0010
636 RHEUMATOID ARTHRITIS 114 0.0010
637 NEPHROLITHIASIS 46 0.0010
638 PLEURAL EFFUSION 61 0.0010
639 MOBILITY DECREASED 72 0.0010
640 THROAT TIGHTNESS 27 0.0010
641 PLATELET COUNT INCREASED 13 0.0010
642 INCREASED APPETITE 19 0.0010
643 HAEMATURIA 34 0.0010
644 DRUG DOSE OMISSION 164 0.0010
645 LIP DRY 9 0.0010
646 MENTAL IMPAIRMENT 24 0.0010
647 BEDRIDDEN 13 0.0010
648 PULMONARY CONGESTION 13 0.0010
649 DISORIENTATION 39 0.0010
650 EYELID PTOSIS 10 0.0010
651 CONFUSIONAL STATE 159 0.0010
652 CARDIAC DISORDER 92 0.0010
653 NIGHTMARE 34 0.0010
654 HALLUCINATION 74 0.0010
655 DRUG DISPENSING ERROR 15 0.0010
656 MOTOR DYSFUNCTION 10 0.0010
657 CHILLS 115 0.0010
658 HEADACHE 615 0.0010
659 HAEMATOCHEZIA 54 0.0010
660 SUBDURAL HAEMATOMA 14 0.0010
661 EAR INFECTION 26 0.0010
662 CHROMATURIA 22 0.0010
663 SKIN FISSURES 19 0.0010
664 PRODUCT QUALITY ISSUE 132 0.0010
665 HEART RATE DECREASED 34 0.0010
666 CYST 12 0.0010
667 CONVULSION 55 0.0010
668 ACUTE RESPIRATORY DISTRESS SYNDROME 17 0.0010
669 TENDERNESS 10 0.0010
670 DYSARTHRIA 36 0.0010
671 MUSCLE TWITCHING 22 0.0010
672 PRESCRIBED UNDERDOSE 19 0.0010
673 ACUTE HEPATIC FAILURE 13 0.0010
674 ANGIOEDEMA 42 0.0009
675 PRODUCT PACKAGING ISSUE 9 0.0009
676 PROTEINURIA 18 0.0009
677 PANCREATITIS 50 0.0009
678 CLOSTRIDIUM DIFFICILE COLITIS 10 0.0009
679 EMOTIONAL DISORDER 29 0.0009
680 POST PROCEDURAL COMPLICATION 18 0.0009
681 BLOOD GLUCOSE DECREASED 45 0.0009
682 SWELLING FACE 61 0.0009
683 ENCEPHALOPATHY 23 0.0009
684 INFLUENZA LIKE ILLNESS 77 0.0009
685 HUNGER 13 0.0009
686 HYPOGLYCAEMIA 45 0.0009
687 DEPRESSED MOOD 49 0.0009
688 HAEMATOMA 24 0.0009
689 DIPLOPIA 24 0.0009
690 ASTHMA 104 0.0009
691 BIPOLAR DISORDER 10 0.0009
692 COELIAC DISEASE 9 0.0009
693 PNEUMONIA 297 0.0009
694 INFLAMMATION 47 0.0009
695 GASTROINTESTINAL PAIN 10 0.0009
696 MELAENA 20 0.0009
697 DRY SKIN 121 0.0009
698 DISEASE RECURRENCE 43 0.0009
699 RASH 394 0.0009
700 INTENTIONAL PRODUCT MISUSE 79 0.0009
701 VENTRICULAR FIBRILLATION 10 0.0009
702 HYPERTENSIVE CRISIS 10 0.0009
703 VAGINAL HAEMORRHAGE 39 0.0009
704 HYPOKINESIA 13 0.0009
705 WOUND 25 0.0009
706 MALNUTRITION 10 0.0009
707 SLEEP DISORDER 63 0.0009
708 RASH PAPULAR 20 0.0009
709 SEROTONIN SYNDROME 17 0.0009
710 CARDIO-RESPIRATORY ARREST 37 0.0009
711 RESPIRATORY TRACT INFECTION 23 0.0009
712 CIRCULATORY COLLAPSE 15 0.0009
713 EUPHORIC MOOD 9 0.0009
714 ABSCESS 14 0.0009
715 EAR DISCOMFORT 9 0.0009
716 THERAPY CESSATION 45 0.0009
717 GASTRIC DISORDER 30 0.0009
718 COLON CANCER 13 0.0009
719 SENSORY DISTURBANCE 14 0.0009
720 PARANOIA 15 0.0009
721 BLOOD CREATINE PHOSPHOKINASE INCREASED 25 0.0009
722 TOOTH LOSS 18 0.0009
723 INJECTION SITE IRRITATION 11 0.0009
724 MALAISE 379 0.0009
725 EYELID OEDEMA 10 0.0009
726 HYPOACUSIS 37 0.0009
727 DERMATITIS 18 0.0009
728 MASS 12 0.0009
729 VASCULITIS 10 0.0009
730 MULTIPLE SCLEROSIS 41 0.0009
731 VISUAL IMPAIRMENT 106 0.0009
732 VOMITING 401 0.0009
733 HEPATIC CIRRHOSIS 16 0.0009
734 FREQUENT BOWEL MOVEMENTS 23 0.0009
735 DRUG INTERACTION 135 0.0009
736 BLINDNESS UNILATERAL 12 0.0008
737 PHOTOPHOBIA 16 0.0008
738 PANIC ATTACK 31 0.0008
739 DRUG ADMINISTRATION ERROR 26 0.0008
740 ABDOMINAL PAIN 197 0.0008
741 HYPOTENSION 169 0.0008
742 HEPATIC ENZYME INCREASED 57 0.0008
743 ORAL CANDIDIASIS 11 0.0008
744 PULMONARY FIBROSIS 16 0.0008
745 GLYCOSYLATED HAEMOGLOBIN INCREASED 21 0.0008
746 PHARYNGITIS STREPTOCOCCAL 9 0.0008
747 HAEMATEMESIS 21 0.0008
748 HEPATITIS C 10 0.0008
749 MENTAL DISORDER 36 0.0008
750 ERYTHEMA 170 0.0008
751 HYPERSENSITIVITY 153 0.0008
752 APATHY 12 0.0008
753 GASTROENTERITIS 12 0.0008
754 ASPIRATION 9 0.0008
755 TACHYCARDIA 73 0.0008
756 BLOOD LACTATE DEHYDROGENASE INCREASED 13 0.0008
757 QUALITY OF LIFE DECREASED 11 0.0008
758 SKIN EXFOLIATION 69 0.0008
759 INTENTIONAL DRUG MISUSE 17 0.0008
760 PRODUCT TASTE ABNORMAL 11 0.0008
761 PRODUCT DOSE OMISSION 53 0.0008
762 CARDIAC ARREST 67 0.0008
763 INJECTION SITE EXTRAVASATION 10 0.0008
764 PLATELET COUNT DECREASED 86 0.0008
765 INJECTION SITE PRURITUS 54 0.0008
766 HALLUCINATION, VISUAL 17 0.0008
767 AGITATION 59 0.0008
768 HAEMORRHAGE INTRACRANIAL 12 0.0008
769 BLOOD GLUCOSE INCREASED 151 0.0008
770 PANCREATITIS ACUTE 18 0.0008
771 BLOOD POTASSIUM INCREASED 13 0.0008
772 INJECTION SITE DISCOLOURATION 10 0.0008
773 IRRITABILITY 48 0.0008
774 HEPATIC FAILURE 24 0.0008
775 SKIN BURNING SENSATION 57 0.0008
776 IMPAIRED WORK ABILITY 17 0.0008
777 APPLICATION SITE PRURITUS 18 0.0008
778 RESTLESSNESS 29 0.0008
779 ABDOMINAL PAIN LOWER 20 0.0008
780 SURGERY 46 0.0008
781 NEOPLASM 9 0.0008
782 URINARY RETENTION 26 0.0008
783 METASTASES TO LUNG 9 0.0008
784 INJECTION SITE HAEMORRHAGE 62 0.0008
785 OSTEONECROSIS OF JAW 19 0.0008
786 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 13 0.0008
787 KIDNEY INFECTION 15 0.0008
788 DISTURBANCE IN ATTENTION 41 0.0008
789 INJECTION SITE PAIN 233 0.0008
790 ATAXIA 9 0.0008
791 RESPIRATORY FAILURE 55 0.0008
792 INFLUENZA 84 0.0008
793 INJECTION SITE BRUISING 60 0.0008
794 POLYNEUROPATHY 9 0.0008
795 BACTERIAL INFECTION 14 0.0007
796 BLOOD PRESSURE FLUCTUATION 18 0.0007
797 TREATMENT NONCOMPLIANCE 41 0.0007
798 WHITE BLOOD CELL COUNT DECREASED 81 0.0007
799 PRODUCT PHYSICAL ISSUE 15 0.0007
800 ILL-DEFINED DISORDER 45 0.0007
801 COLITIS 28 0.0007
802 NO THERAPEUTIC RESPONSE 9 0.0007
803 UVEITIS 10 0.0007
804 CONDITION AGGRAVATED 224 0.0007
805 HAEMORRHAGE 77 0.0007
806 RESPIRATORY DISORDER 22 0.0007
807 LUNG DISORDER 36 0.0007
808 URTICARIA 123 0.0007
809 IMPAIRED GASTRIC EMPTYING 10 0.0007
810 PRODUCTIVE COUGH 35 0.0007
811 THIRST 13 0.0007
812 APPLICATION SITE PAIN 16 0.0007
813 GASTROINTESTINAL DISORDER 65 0.0007
814 INSURANCE ISSUE 11 0.0007
815 POISONING 9 0.0007
816 INTESTINAL OBSTRUCTION 27 0.0007
817 DERMATITIS ALLERGIC 9 0.0007
818 ASPARTATE AMINOTRANSFERASE INCREASED 38 0.0007
819 RASH ERYTHEMATOUS 34 0.0007
820 CANDIDA INFECTION 12 0.0007
821 DELUSION 11 0.0007
822 DISABILITY 14 0.0007
823 INJECTION SITE MASS 26 0.0007
824 BRAIN FOG 11 0.0007
825 OCULAR HYPERAEMIA 33 0.0007
826 ADVERSE EVENT 64 0.0007
827 PERICARDIAL EFFUSION 16 0.0007
828 ANOSMIA 10 0.0007
829 SEPSIS 77 0.0007
830 FEEDING DISORDER 14 0.0007
831 HAND DEFORMITY 9 0.0007
832 PROCEDURAL PAIN 19 0.0007
833 EOSINOPHILIA 12 0.0007
834 BLOOD ALKALINE PHOSPHATASE INCREASED 17 0.0007
835 EYE PRURITUS 23 0.0007
836 INJECTION SITE RASH 21 0.0007
837 INJECTION SITE ERYTHEMA 84 0.0007
838 MIGRAINE 64 0.0007
839 EYE DISORDER 22 0.0007
840 JAUNDICE 18 0.0007
841 DEVICE MALFUNCTION 47 0.0007
842 PAIN OF SKIN 18 0.0007
843 BONE LOSS 10 0.0007
844 DELIRIUM 23 0.0007
845 PALLOR 18 0.0007
846 DRUG TOXICITY 9 0.0007
847 DRUG INEFFECTIVE 861 0.0007
848 BLOOD GLUCOSE ABNORMAL 12 0.0006
849 APPLICATION SITE ERYTHEMA 17 0.0006
850 SYSTEMIC LUPUS ERYTHEMATOSUS 23 0.0006
851 EXTRAPYRAMIDAL DISORDER 16 0.0006
852 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 15 0.0006
853 THERAPEUTIC RESPONSE DECREASED 39 0.0006
854 CEREBRAL HAEMORRHAGE 23 0.0006
855 OXYGEN SATURATION DECREASED 36 0.0006
856 OSTEONECROSIS 21 0.0006
857 ALANINE AMINOTRANSFERASE INCREASED 39 0.0006
858 VIRAL INFECTION 21 0.0006
859 BLOOD BILIRUBIN INCREASED 17 0.0006
860 INFECTION 91 0.0006
861 GAIT INABILITY 21 0.0006
862 DRUG WITHDRAWAL SYNDROME 55 0.0006
863 COVID-19 109 0.0006
864 DRUG INTOLERANCE 60 0.0006
865 ANGER 21 0.0006
866 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 34 0.0006
867 INCORRECT DOSE ADMINISTERED 141 0.0006
868 RESPIRATORY ARREST 17 0.0006
869 ISCHAEMIC STROKE 11 0.0006
870 CEREBRAL INFARCTION 15 0.0006
871 BLINDNESS 25 0.0006
872 METASTASES TO BONE 10 0.0006
873 DEMENTIA 17 0.0006
874 PRODUCT USE ISSUE 113 0.0006
875 PRODUCT DOSE OMISSION ISSUE 176 0.0006
876 PRODUCT DISPENSING ERROR 13 0.0006
877 INTENTIONAL DOSE OMISSION 17 0.0006
878 CLOSTRIDIUM DIFFICILE INFECTION 13 0.0006
879 CONJUNCTIVITIS 11 0.0006
880 DEVICE FAILURE 9 0.0006
881 THROMBOCYTOPENIA 66 0.0006
882 SUICIDAL IDEATION 54 0.0006
883 MULTIPLE SCLEROSIS RELAPSE 40 0.0006
884 DIABETIC KETOACIDOSIS 14 0.0006
885 ILLNESS 60 0.0006
886 ASCITES 17 0.0006
887 NERVOUS SYSTEM DISORDER 18 0.0006
888 DISCOMFORT 35 0.0006
889 ECZEMA 30 0.0006
890 MUCOSAL INFLAMMATION 15 0.0006
891 PRODUCT USE COMPLAINT 9 0.0006
892 METABOLIC ACIDOSIS 18 0.0006
893 DEVICE ISSUE 50 0.0006
894 COGNITIVE DISORDER 26 0.0006
895 CARDIOVASCULAR DISORDER 14 0.0006
896 PELVIC PAIN 10 0.0005
897 NEEDLE ISSUE 16 0.0005
898 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 99 0.0005
899 DRUG LEVEL INCREASED 9 0.0005
900 BONE DENSITY DECREASED 17 0.0005
901 PYREXIA 187 0.0005
902 LEUKOPENIA 27 0.0005
903 HYPOXIA 19 0.0005
904 SEDATION 14 0.0005
905 PRODUCT USE IN UNAPPROVED INDICATION 132 0.0005
906 DISEASE PROGRESSION 62 0.0005
907 WITHDRAWAL SYNDROME 22 0.0005
908 INJECTION SITE SWELLING 40 0.0005
909 SHOCK 12 0.0005
910 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 25 0.0005
911 BREAST CANCER 48 0.0005
912 DRUG-INDUCED LIVER INJURY 16 0.0005
913 LYMPHOCYTE COUNT DECREASED 9 0.0005
914 INJECTION SITE REACTION 35 0.0005
915 DRUG ERUPTION 9 0.0005
916 PRODUCT PRESCRIBING ISSUE 11 0.0005
917 ABNORMAL BEHAVIOUR 20 0.0005
918 PANCYTOPENIA 28 0.0005
919 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 101 0.0005
920 STEVENS-JOHNSON SYNDROME 11 0.0005
921 THERAPY NON-RESPONDER 22 0.0005
922 INJECTION SITE URTICARIA 12 0.0005
923 NEOPLASM PROGRESSION 17 0.0005
924 INJECTION SITE WARMTH 10 0.0005
925 MEDICATION ERROR 27 0.0005
926 INTENTIONAL PRODUCT USE ISSUE 42 0.0005
927 FRACTURE 9 0.0005
928 GENERAL PHYSICAL HEALTH DETERIORATION 55 0.0005
929 PSYCHOTIC DISORDER 14 0.0005
930 LIVER DISORDER 21 0.0005
931 RESPIRATORY DISTRESS 13 0.0005
932 MOOD SWINGS 15 0.0005
933 HEPATITIS 12 0.0005
934 INFUSION RELATED REACTION 31 0.0005
935 OFF LABEL USE 408 0.0005
936 PRESCRIBED OVERDOSE 9 0.0005
937 THERAPEUTIC RESPONSE SHORTENED 15 0.0005
938 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 32 0.0004
939 RASH MACULO-PAPULAR 10 0.0004
940 PRODUCT ADHESION ISSUE 16 0.0004
941 ELECTROCARDIOGRAM QT PROLONGED 16 0.0004
942 MOOD ALTERED 12 0.0004
943 PRODUCT AVAILABILITY ISSUE 10 0.0004
944 SEPTIC SHOCK 19 0.0004
945 CARDIAC FAILURE 35 0.0004
946 CONTRAINDICATED PRODUCT ADMINISTERED 13 0.0004
947 COLITIS ULCERATIVE 19 0.0004
948 PRODUCT DOSE OMISSION IN ERROR 12 0.0004
949 ADVERSE DRUG REACTION 38 0.0004
950 PANCREATIC CARCINOMA 12 0.0004
951 PNEUMONITIS 11 0.0004
952 MALIGNANT NEOPLASM PROGRESSION 41 0.0004
953 SEIZURE 46 0.0004
954 NEUTROPHIL COUNT DECREASED 16 0.0004
955 THERAPY INTERRUPTED 28 0.0004
956 NEOPLASM MALIGNANT 26 0.0004
957 THERAPEUTIC PRODUCT EFFECT DECREASED 17 0.0004
958 LOWER RESPIRATORY TRACT INFECTION 17 0.0004
959 TOXICITY TO VARIOUS AGENTS 62 0.0004
960 LUNG NEOPLASM MALIGNANT 15 0.0004
961 FEBRILE NEUTROPENIA 24 0.0004
962 DERMATITIS ATOPIC 19 0.0004
963 C-REACTIVE PROTEIN INCREASED 13 0.0004
964 ACCIDENTAL EXPOSURE TO PRODUCT 36 0.0003
965 EXPOSURE VIA SKIN CONTACT 9 0.0003
966 EXTRA DOSE ADMINISTERED 14 0.0003
967 ACNE 25 0.0003
968 ACCIDENTAL OVERDOSE 12 0.0003
969 ANAPHYLACTIC REACTION 18 0.0003
970 NEUTROPENIA 43 0.0003
971 RHABDOMYOLYSIS 13 0.0003
972 PROSTATE CANCER 25 0.0003
973 LACTIC ACIDOSIS 10 0.0003
974 SKIN IRRITATION 14 0.0003
975 DEATH 262 0.0003
976 HOSPITALISATION 46 0.0003
977 NO ADVERSE EVENT 54 0.0003
978 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 10 0.0003
979 AGGRESSION 13 0.0003
980 PLASMA CELL MYELOMA 10 0.0003
981 DEPRESSED LEVEL OF CONSCIOUSNESS 10 0.0003
982 RENAL CANCER 12 0.0003
983 INTENTIONAL OVERDOSE 16 0.0002
984 DEVICE BREAKAGE 10 0.0002
985 SUICIDE ATTEMPT 14 0.0002
986 DEVICE LEAKAGE 10 0.0002
987 DEVICE DISLOCATION 10 0.0002
988 OVERDOSE 49 0.0002
989 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 10 0.0002
990 DEVICE DIFFICULT TO USE 9 0.0001
991 TREATMENT FAILURE 11 0.0001
992 DRUG DEPENDENCE 14 0.0001